Skip to main content

Table 3 Effect of statin according to initial concentration of total cholesterol. Most commonly used dose in the trials.

From: Statins in hypercholesterolaemia: A dose-specific meta-analysis of lipid changes in randomised, double blind trials

    

Weighted mean change from baseline

Number of trials

Number of patients

Initial [TC]*

Weighted mean initial [TC]*

Absolute

Percent

Cerivastatin 0.4 mg

     

2

527

All combined

7.0

-1.7

-25

1

332

6.0–6.9

6.8

-1.8

-26

1

195

7.0–7.9

7.2

-1.7

-24

Fluvastatin 40 mg

     

5

376

All combined

7.6

-1.3

-17

1

25

6.0–6.9

6.4

-0.8

-12

3

287

7.0–7.9

7.4

-1.3

-18

1

40

9.0–9.9

9.1

-1.6

-17

Lovastatin 40 mg

     

7

3743

All combined

6.8

-1.5

-23

2

3436

6.0–6.9

6.7

-1.5

-23

1

211

7.0–7.9

7.0

-1.4

-20

1

96

9.0–9.9

9.6

-2.1

-22

Pravastatin 40 mg

     

17

6635

All combined

6.5

-1.3

-20

2

261

5.0–5.9

5.4

-1.1

-20

8

2315

6.0–6.9

6.2

-1.1

-18

6

3866

7.0–7.9

7.1

-1.4

-20

1

193

9.0–9.9

9.2

-2.1

-23

Simvastatin 40 mg

     

4

10952

All combined

5.7

-1.5

-26

1

10269

5.0–5.9

5.6

-1.5

-26

1

41

6.0–6.9

6.7

-1.8

-27

1

206

7.0–7.9

7.0

-1.9

-28

1

436

8.0–8.9

8.1

-2.5

-31

  1. * Initial [TC]: mean concentration of total cholesterol, in mmol/L, at baseline